MDMB-CHMINACA
 | |
| Identifiers | |
|---|---|
| |
| CAS Number | |
| ChemSpider | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C22H31N3O3 |
| Molar mass | 385.5 g/mol g·mol−1 |
| 3D model (JSmol) | |
| |
| |
MDMB-CHMINACA (also known as MDMB(N)-CHM) is an indazole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug.[1][2][3][4] It is closely related to MDMB-FUBINACA, which caused at least 1000 hospitalizations and 40 deaths in Russia as consequence of intoxication.[5]
Legal status
MDMB-CHMINACA is listed in the Fifth Schedule of the Misuse of Drugs Act (MDA) and therefore illegal in Singapore as of May 2015.[6]
See also
References
- ^ "MDMB-CHMINACA". Cayman Chemical. Retrieved 14 July 2015.
- ^ Shevyrin V, Melkozerov V, Nevero A, Eltsov O, Shafran Y, Morzherin Y, Lebedev AT (Apr 2015). "Identification and analytical characteristics of synthetic cannabinoids with an indazole-3-carboxamide structure bearing a N-1-methoxycarbonylalkyl group". Analytical and Bioanalytical Chemistry. 407: 6301–15. doi:10.1007/s00216-015-8612-7. PMID 25893797.
- ^ Prof. SA Savchuk (2014). "Detection methods of psychoactive substances and liquid chromotograoghy detection of metabolites" (PDF). Russian Ministry of Health. Retrieved 14 July 2015.
- ^ "Идентификация синтетических каннабимиметиков MDMB-CHMINACA, MDMB-FUBINACA и их метаболитов". CTS "SCIENCE". Retrieved 14 July 2015.
- ^ "Очередная жертва спайса". Federal Drug Control Service of the Russian Federation. 17 March 2015. Retrieved 13 July 2015.
- ^ "CNB NEWS RELEASE". Central Narcotics Bureau (CNB). 30 April 2015. Retrieved 14 July 2015.
 | This cannabinoid related article is a stub. You can help Wikipedia by expanding it. |